• HOME
• ABOUT US
  • Company Profile
  • CRO's & Pharmaceutical Companies
• COMPANY BIOS
  • Jeff Stein
  • David M. Radin, MD
  • Judith Dalgin
  • Svetlana Konnov, LPN
  • Betsy Kempner, RN
  • Patrick Brew, MD, RN
  • Tulie Brew, MD
  • Anju Sherstha, MD
• CURRENT TRIALS
  • Chronic Lower Back Pain
  • Chronic Pain
  • Interstitial Cystitis / Painful Bladder Syndrome
  • Osteoarthritis
• CONDITIONS
• CONTACT US

Lipid Storage Disorders

Lipid storage disorders, or lipidoses, are a category of genetic metabolic disorders characterized by harmful levels of excessive lipids that may accumulate in the cells and tissues. The body does not produce enough enzymes to metabolize the fats, causing cellular and tissue damage over time. Permanent damage can occur in the brain, peripheral nervous system, liver, spleen and bone marrow.

Related disorders may include:

• Fabry disease
• Farber disease
• Fucosidosis
• Gaucher disease
• GM1 Gangliosidoses
• GM2 Gangliosidoses
• Krabbe Disease
• Metachromatic Leukodystrophy (MLD)
• Multiple Sulfatase Deficiency
• Niemann-Pick disease
• Schindler Disease
• Wolman Disease

Sorry, Stamford Therapeutics Consortium is not currently conducting a study in this category. Please check back, as we are adding new studies all the time. You can also feel free to contact Judy Dalgin our Site Manager for more information about upcoming trials.

Judy Dalgin (Site Manager)
email: jdalgin@stctrials.com
telephone: 203-325-8529